Silverlon® Antimicrobial Dressing Line Receives Contract Extension from Vizient, Inc.

GENEVA, Ill., Feb. 19, 2019 /PRNewswire-PRWeb/ -- Cura Surgical announced that their existing Vizient Contract (number MS11396) has been extended through January 31, 2021. This contract allows a comprehensive line of unique silver-plated nylon dressings in both Silverlon® and TheraBond® product ranges to be available to Vizient members across the nation. Vizient represents a diverse membership base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers representing more than $100 billion in annual purchasing volume.

"We are thrilled to extend enhanced savings on our Silverlon® product line through this contract to Vizient members," said Raul Brizuela, president and CEO of Cura Surgical and Argentum Medical, provider of Silverlon. "Combating hospital acquired infections, including surgical site infections, remains a top priority to healthcare facilities, and we are proud make a positive impact in this field."

Silverlon® antimicrobial silver-plated dressings provide 50-100xs more silver than other silver-based antimicrobial dressings, and Silverlon's efficacy is supported by multiple independent, peer-reviewed and published clinical studies. These studies suggest Silverlon® Dressings can be an important element in wound care and that control of wound bacteria within the dressing may help reduce the risk of infection.

About Silverlon®
Silverlon® wound dressings have a permanently plated metallic surface, which provides the antimicrobial benefits of silver in the dressing without staining the skin and without increasing bioburden. Silverlon was originally developed for the U.S. military, where it is still extensively used for management of burn and blast injuries. Silverlon® dressings are used today by surgeons and other healthcare professionals around the world on surgical wounds, in negative pressure wound therapy, on chronic wounds, burns, skin grafts, and IV and catheter-related wounds.

Silverlon® Island Wound Dressings and Silverlon® Wound Pad Dressings are indicated for the management of infected wounds, as the silver in the dressing provides an antimicrobial barrier that may be helpful in managing these wounds. In addition, the moist wound healing environment and control of wound bacteria within the Silverlon® Island Wound Dressing and Silverlon® Wound Pad Dressing may help reduce the risk of wound infection and support the body's healing process. Silverlon® Island Wound Dressings and Silverlon® Wound Pad Dressing's non-adherent wound contact layer reduces pain during dressing changes and evaporation of moisture in the dressing may soothe the wound. For more information and complete indications for use, visit http://www.silverlon.com as well as Twitter and LinkedIn pages.

About Cura Surgical
Building on a foundation of more than 35 years of creating breakthrough surgical devices, Cura Surgical, an Argentum Medical company, provides solutions designed to enhance the overall surgical experience for patients and surgeons.

###

SOURCE Silverlon